Royal Philips
Philips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System receives FDA 510(k) clearance
Philips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System receives FDA 510(k) clearance
April 6, 2021
Intuitive, table-side touchscreen control offers interventionalists enhanced diagnostic confidence and streamlined workflows [1]
Full control of image acquisition and analysis from within the sterile zone helps to avoid procedure disruption, saving time and allowing interventionalists to stay focused on their patients
Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. Food and Drug Administration 510 (k) clearance for its Philips SmartCT application software. SmartCT is a key component of Philips Image Guided Therapy System – Azurion – providing interventionalists with CT-l